trial · primary record
Investigator's Choice Chemotherapy (FOLFIRI or FOLFOX regimen)
Extrapulmonary Neuroendocrine Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 270 |
| Primary completion | 2030-06-30 |
| Primary endpoint | Overall survival (OS) |
| Registry ID | NCT07894211 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:47.361Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07894211
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.